tradingkey.logo
搜索

Revolution Medicines Inc

RVMD
添加自选
184.000USD
-4.070-2.16%
收盘 07-28 16:00美东报价延迟15分钟
36.25B总市值
亏损市盈率 TTM

RVMD 财务数据

通过专为投资者打造的一站式数据看板,全面查看 Revolution Medicines Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

Revolution Medicines Inc财报日历

最新发布
5月 6, 2026
每股收益 / 预测值
-2.29/-1.46
营业收入 / 预测值
--/2.42M
报告期
FY2025 财报
营业收入(YoY)
--
--
每股收益(YoY)
-5.95
-66.32%
分析师评级
BUY
2026/07/28
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
-101.96%-2.29
-67.95%-1.88
-72.18%-1.61
-62.86%-1.31
-61.08%-1.13
2.18%-1.12
5.64%-0.94
12.28%-0.81
1.93%-0.70
-80.33%-1.14
---0.99
---0.92
---0.72
---0.63
---2.47
----
----
----
----
----
营业收入
----
--0.00
--0.00
----
----
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
-95.16%742.00K
-100.00%0.00
-58.05%3.82M
-7.44%7.01M
62.05%15.33M
204.81%3.36M
4.81%9.12M
-25.20%7.58M
8.10%9.46M
-91.30%1.10M
-13.24%8.70M
净利润
-112.64%-453.82M
-87.54%-364.89M
-95.28%-305.21M
-85.98%-247.79M
-83.97%-213.42M
-20.45%-194.57M
-44.13%-156.29M
-35.54%-133.23M
-70.35%-116.00M
-185.87%-161.54M
-47.87%-108.43M
-60.56%-98.30M
-18.13%-68.10M
-7.27%-56.51M
-38.51%-73.33M
-38.20%-61.22M
-55.07%-57.65M
-54.01%-52.68M
-94.48%-52.94M
-62.77%-44.30M
利润率
----
----
----
----
----
----
----
----
----
-5806.20%-21770.49%
----
---2570.55%
---970.89%
---368.60%
---958.59%
----
----
----
----
----
毛利率
----
----
----
----
----
----
----
----
----
0.00%100.00%
----
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
资产负债率
--12.45%
--11.40%
--11.39%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
营业收入
----
--0.00
--0.00
----
----
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
-95.16%742.00K
-100.00%0.00
-58.05%3.82M
-7.44%7.01M
62.05%15.33M
204.81%3.36M
4.81%9.12M
-25.20%7.58M
8.10%9.46M
-91.30%1.10M
-13.24%8.70M
营业利润
-84.92%-445.22M
-67.18%-361.63M
-79.42%-315.27M
-68.99%-264.71M
-70.92%-240.76M
-20.18%-216.31M
-42.57%-175.71M
-43.98%-156.64M
-87.42%-140.86M
-191.67%-179.98M
-61.04%-123.25M
-75.23%-108.80M
-29.70%-75.16M
-16.62%-61.71M
-43.96%-76.53M
-39.42%-62.09M
-54.96%-57.95M
-55.26%-52.91M
-92.96%-53.16M
-59.14%-44.53M
净利润
-112.64%-453.82M
-87.54%-364.89M
-95.28%-305.21M
-85.98%-247.79M
-83.97%-213.42M
-20.45%-194.57M
-44.13%-156.29M
-35.54%-133.23M
-70.35%-116.00M
-185.87%-161.54M
-47.87%-108.43M
-60.56%-98.30M
-18.13%-68.10M
-7.27%-56.51M
-38.51%-73.33M
-38.20%-61.22M
-55.07%-57.65M
-54.01%-52.68M
-94.48%-52.94M
-62.77%-44.30M
流动资产
-7.81%1.97B
-10.85%2.08B
25.23%1.98B
33.96%2.18B
23.44%2.13B
23.86%2.33B
91.53%1.58B
76.20%1.62B
87.40%1.73B
184.66%1.88B
22.12%824.47M
90.89%922.09M
72.69%922.75M
11.94%660.18M
8.27%675.11M
-26.92%483.05M
-23.38%534.34M
29.87%589.77M
29.12%623.54M
94.20%661.01M
流动负债总额
82.60%289.60M
77.18%290.42M
121.55%245.62M
75.19%184.53M
69.22%158.60M
13.95%163.91M
29.60%110.86M
34.94%105.33M
71.54%93.72M
132.08%143.85M
16.75%85.54M
22.85%78.06M
-4.91%54.63M
2.71%61.98M
41.20%73.27M
38.73%63.54M
31.31%57.46M
27.93%60.35M
22.43%51.89M
4.72%45.80M
总资产
-4.72%2.25B
-7.97%2.35B
27.73%2.25B
34.35%2.43B
23.95%2.37B
24.09%2.56B
79.12%1.76B
68.43%1.81B
77.81%1.91B
153.93%2.06B
19.17%984.23M
69.68%1.07B
57.19%1.07B
10.02%811.93M
12.37%825.91M
-18.25%632.80M
-15.88%682.77M
30.06%737.99M
23.51%734.98M
70.51%774.05M
总负债
162.47%753.82M
146.75%723.21M
233.01%655.02M
197.59%564.20M
57.03%287.20M
24.45%293.10M
34.01%196.69M
32.70%189.59M
51.12%182.90M
85.82%235.51M
1.58%146.77M
6.65%142.87M
-8.16%121.03M
-6.41%126.74M
49.31%144.49M
50.45%133.96M
47.95%131.78M
46.04%135.42M
7.52%96.77M
-4.73%89.04M
总权益
-27.82%1.50B
-27.98%1.63B
1.95%1.60B
15.23%1.87B
20.44%2.08B
24.04%2.27B
87.03%1.57B
73.91%1.62B
81.21%1.73B
166.52%1.83B
22.90%837.46M
86.60%930.84M
72.82%952.22M
13.71%685.19M
6.77%681.42M
-27.18%498.84M
-23.75%550.99M
26.94%602.57M
26.36%638.20M
90.02%685.01M
经营净额
-82.15%-354.17M
-98.31%-274.24M
-58.96%-207.31M
-73.02%-221.76M
-21.10%-194.44M
-14.70%-138.29M
-29.77%-130.42M
-90.95%-128.17M
-157.34%-160.56M
-95.12%-120.56M
-94.25%-100.50M
-20.47%-67.12M
-13.11%-62.39M
-57.36%-61.79M
-41.40%-51.74M
-63.48%-55.72M
-48.10%-55.16M
-56.85%-39.27M
-35.41%-36.59M
-70.48%-34.08M
投资净额
1182.29%172.62M
119.06%74.88M
215.74%24.85M
-68.25%34.28M
93.57%-15.95M
-3.29%-392.90M
-127.75%-21.47M
347.90%107.94M
-6305.36%-247.97M
-5254.76%-380.40M
162.66%77.35M
-169.78%-43.54M
-90.92%4.00M
-183.25%-7.10M
-309.05%-123.44M
150.82%62.40M
1806.67%44.02M
-86.44%8.53M
70.11%-30.18M
10.05%-122.78M
融资净额
27216.25%238.74M
-58.15%365.66M
-102.06%-1.59M
3319.28%256.58M
7.90%874.00K
4.10%873.80M
7545.30%77.29M
-88.39%7.50M
-99.75%810.00K
1534.16%839.35M
-99.59%1.01M
4422.74%64.63M
106196.72%324.20M
378.78%51.36M
77747.96%248.34M
64.63%1.43M
-99.89%305.00K
622.42%10.73M
-99.81%319.00K
164.97%868.00K

常见问题

Revolution Medicines Inc的流动资产是多少?

根据Revolution Medicines Inc的FY2025财报,流动资产为2.08B(同比变化-10.85)。

Revolution Medicines Inc的总资产是多少?

根据Revolution Medicines Inc的FY2025财报,Revolution Medicines Inc的总资产为2.35B(同比变化-7.97)。

Revolution Medicines Inc的总负债是多少?

根据Revolution Medicines Inc的FY2025财报,Revolution Medicines Inc的总负债为723.21M(同比变化146.75)。

Revolution Medicines Inc的总权益是多少?

根据Revolution Medicines Inc的FY2025财报,Revolution Medicines Inc的总权益为1.63B(同比变化-27.98)。

Revolution Medicines Inc的净营业收入是多少?

根据Revolution Medicines Inc的FY2025财报,Revolution Medicines Inc的净营业收入为-1.18B(同比变化-71.48)。

Revolution Medicines Inc的净投资是多少?

根据Revolution Medicines Inc的FY2025财报,Revolution Medicines Inc的净投资为118.06M(同比变化121.29)。

Revolution Medicines Inc的净融资是多少?

根据Revolution Medicines Inc的FY2025财报,Revolution Medicines Inc的净融资为621.52M(同比变化-35.22)。

Revolution Medicines Inc的每股收益(EPS)是多少?

根据Revolution Medicines Inc的FY2025财报,每股收益(EPS)为-5.95(同比变化-66.32)。

Revolution Medicines Inc的净利润是多少?

根据Revolution Medicines Inc的FY2025财报,净利润为-1.13B(同比变化-88.52)。

Revolution Medicines Inc的股东权益回报率(ROE)是多少?

根据Revolution Medicines Inc的FY2025财报,股东权益回报率(ROE)为-58.07(同比变化-97.95)。

Revolution Medicines Inc的资产回报率(ROA)是多少?

根据Revolution Medicines Inc的FY2025财报,资产回报率(ROA)为-46.06(同比变化-77.29)。

Revolution Medicines Inc的营业利润是多少?

根据Revolution Medicines Inc的FY2025财报,营业利润为-1.18B(同比变化-71.48)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有